Coherus Oncology, Inc. Tax Withholding Paid on Stock Awards
Coherus Oncology, Inc. (CHRS) reported Tax Withholding Paid on Stock Awards of $112.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-05
- Coherus Oncology, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Coherus Oncology, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $112.00K, a 57.58% decline year-over-year.
- Coherus Oncology, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Coherus Oncology, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $3.00K, a 70.00% decline year-over-year.
- Coherus Oncology, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $283.00K, a 88.57% decline from fiscal 2024.
- Coherus Oncology, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $2.48M.
- Coherus Oncology, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $3.74M, a 113.58% increase from fiscal 2021.
- Coherus Oncology, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2021 was $1.75M, a 99.20% increase from fiscal 2020.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $112.00K 10-Q · filed 2026-08-05 | $112.00K derived: sum of 3 quarters · filed 2026-08-05 | $115.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $112.00K 10-Q · filed 2026-05-11 | $112.00K derived: sum of 2 quarters · filed 2026-05-11 | $115.00K derived: sum of 3 quarters · filed 2026-05-11 | $131.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $3.00K derived: sum of 2 quarters · filed 2026-03-09 | $19.00K derived: sum of 3 quarters · filed 2026-08-05 | $283.00K 10-K · filed 2026-03-09 |
| 2025-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $19.00K derived: sum of 2 quarters · filed 2026-08-05 | $283.00K 10-Q · filed 2025-11-06 | $293.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $280.00K 10-Q · filed 2026-08-05 | $290.00K derived: sum of 3 quarters · filed 2026-08-05 | $300.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $264.00K 10-Q · filed 2026-05-11 | $274.00K derived: sum of 2 quarters · filed 2026-05-11 | $284.00K derived: sum of 3 quarters · filed 2026-05-11 | $2.00M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $20.00K derived: sum of 2 quarters · filed 2026-03-09 | $1.73M derived: sum of 3 quarters · filed 2026-03-09 | $2.48M 10-K · filed 2026-03-09 |
| 2024-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.72M derived: sum of 2 quarters · filed 2025-11-06 | $2.47M 10-Q · filed 2025-11-06 | $2.79M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.46M 10-Q · filed 2025-08-07 | $2.78M derived: sum of 3 quarters · filed 2025-11-13 | $2.96M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-03-31 | $745.00K 10-Q · filed 2025-05-12 | $1.07M derived: sum of 2 quarters · filed 2025-11-13 | $1.25M derived: sum of 3 quarters · filed 2025-11-13 | $1.55M derived: sum of 4 quarters · filed 2025-11-13 |
| 2023-12-31 | $326.00K derived: 8-K 12 month − 10-Q 9 month · filed 2025-11-13 | $501.00K derived: sum of 2 quarters · filed 2025-11-13 | $806.00K derived: sum of 3 quarters · filed 2025-11-13 | $3.59M 8-K · filed 2025-11-13 |
| 2023-09-30 | $175.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $480.00K derived: sum of 2 quarters · filed 2024-11-06 | $3.26M 10-Q · filed 2024-11-06 | $3.38M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | $305.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $3.09M 10-Q · filed 2024-08-08 | $3.21M derived: sum of 3 quarters · filed 2025-03-17 | $3.53M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | $2.78M 10-Q · filed 2024-05-09 | $2.90M derived: sum of 2 quarters · filed 2025-03-17 | $3.23M derived: sum of 3 quarters · filed 2025-03-17 | $3.87M derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | $123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $444.00K derived: sum of 2 quarters · filed 2025-03-17 | $1.09M derived: sum of 3 quarters · filed 2025-03-17 | $3.74M 10-K · filed 2025-03-17 |
| 2022-09-30 | $321.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $963.00K derived: sum of 2 quarters · filed 2023-11-06 | $3.62M 10-Q · filed 2023-11-06 | $3.64M derived: sum of 4 quarters · filed 2024-03-15 |
| 2022-06-30 | $642.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $3.30M 10-Q · filed 2023-08-02 | $3.32M derived: sum of 3 quarters · filed 2024-03-15 | $3.32M derived: sum of 4 quarters · filed 2024-03-15 |
| 2022-03-31 | $2.66M 10-Q · filed 2023-05-08 | $2.68M derived: sum of 2 quarters · filed 2024-03-15 | $2.68M derived: sum of 3 quarters · filed 2024-03-15 | $2.68M derived: sum of 4 quarters · filed 2024-03-15 |
| 2021-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $23.00K derived: sum of 2 quarters · filed 2024-03-15 | $23.00K derived: sum of 3 quarters · filed 2024-03-15 | $1.75M 10-K · filed 2024-03-15 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $1.73M 10-Q · filed 2022-11-08 | $1.73M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.73M 10-Q · filed 2022-08-04 | $1.73M derived: sum of 3 quarters · filed 2023-03-06 | $1.73M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | $1.73M 10-Q · filed 2022-05-05 | $1.73M derived: sum of 2 quarters · filed 2023-03-06 | $1.73M derived: sum of 3 quarters · filed 2023-03-06 | $1.73M derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $0.00 derived: sum of 2 quarters · filed 2023-03-06 | $0.00 derived: sum of 3 quarters · filed 2023-03-06 | $880.00K 10-K · filed 2023-03-06 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $0.00 derived: sum of 2 quarters · filed 2021-11-08 | $880.00K 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $880.00K 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $880.00K 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $815.00K 10-K · filed 2022-02-23 | |||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-02-27 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |